Medtronic Invades Dialysis Market With Bellco Buy
This article was originally published in Clinica
Medtronic PLC is expanding its presence in the end-stage renal disease device market with the acquisition of hemodialysis company Bellco Health Corp.
You may also be interested in...
The de novo clearance makes the Carpediem system the first commercially available system indicated for continuous renal replacement therapy in pediatric patients.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.